Anti-ISG20 antibody
5
(1 Review)
|
(3 Publications)
Rabbit Polyclonal ISG20 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ISG20 aa 1 to C-terminus.
View Alternative Names
HEM45, ISG20, Interferon-stimulated gene 20 kDa protein, Estrogen-regulated transcript 45 protein, Promyelocytic leukemia nuclear body-associated protein ISG20
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ISG20 antibody (AB154393)
Immunofluorescence analysis of paraformaldehyde-fixed HeLa cells labelling ISG20 with ab154393 at a 1/500 dilution. Co-stained with Hoechst 33342.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ISG20 antibody (AB154393)
Immunohistochemical analysis of paraffin-embedded BT483 xenograft, labelling ISG20 with ab154393 at 1/500 dilution.
- IHC-P
AbReview51270****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ISG20 antibody (AB154393)
Immunohistochemical analysis of formaldehyde-fixed paraffin-embedded human non-Hodgkin lymphoma tissue sections, labelling ISG20 with ab154393 at a dilution of 1/50 incubated for 12 hours at 4°C. Heat mediated antigen retrival was with citrate buffer at pH 6.0 incubated for 15 minutes. Blocking was a with 5% serum incubated for 30 minutes at 25°C. Secondary was a Goat anti-rabbit polyclonal CY3® conjugate at 1/200. Counterstain was with DAPI against nuclear DNA.
Image is courtesy of an AbReview submitted by Dr Assia Angelova.
- WB
Supplier Data
Western blot - Anti-ISG20 antibody (AB154393)
Samples were separated by 12% SDS-PAGE. The signal was developed with Trident ECL plus-Enhanced.
All lanes:
Western blot - Anti-ISG20 antibody (ab154393) at 1/1000 dilution
Lane 1:
Jurkat whole cell extracts at 30 µg
Lane 2:
Raji whole cell extracts at 30 µg
Lane 3:
NCI-H929 whole cell extracts at 30 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG antibody
Predicted band size: 20 kDa
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ISG20 serves as an antiviral factor by degrading viral genomes to restrict infection. It does not work alone; often it functions as part of a larger antiviral mechanism alongside other interferon-induced proteins like PKR and OAS. Through its RNA-degrading activity ISG20 contributes significantly to controlling the spread of viruses by breaking down the RNA from invading organisms particularly RNA viruses. This makes ISG20 an important player in reducing viral loads during infections.
Pathways
ISG20 is mainly associated with the interferon signaling pathway where it acts downstream to execute immune processes. It interacts with and complements other antiviral proteins such as RNase L which also plays a role in degrading RNA during viral responses. Additionally ISG20 links to the broader regulation of apoptosis and cell death pathways showing how it assists in eliminating infected cells to prevent further viral proliferation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
EMBO reports 22:e49568 PubMed33969602
2021
Applications
Unspecified application
Species
Unspecified reactive species
Genes to cells : devoted to molecular & cellular mechanisms 26:18-30 PubMed33147372
2020
Applications
Unspecified application
Species
Unspecified reactive species
Intractable & rare diseases research 6:269-273 PubMed29259855
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com